Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis

21 May 2020

Abstract excerpt

Myasthenia gravis (MG) is a rare acquired autoimmune neuromuscular disease. Autoantibodies, cellular immunity, complement, and cytokines are involved in the pathogenesis of MG. It is characterized by the dysfunction of neuromuscular junction transmission and skeletal muscle weakness. MicroRNAs (miRNAs) are non-coding small molecule ribonucleic acids that regulate various biological processes (e.g., development,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Myasthenia Gravis and Thymoma
Share to Parkinson's Disease and Spinal Disorders
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32508584
DOI: 10.3389/fnins.2020.00507

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Roles of Dysregulated MicroRNAs in Myasthenia GravisPMID 32508584Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read ↗

Circulating microRNAs as potential biomarkers in myasthenia gravis patientsSemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Plasma exosomal miR‐106a‐5p expression in myasthenia gravisSemantic proximity Read ↗

Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscleSemantic proximity Read ↗

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravisSemantic proximity Read ↗

Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenuesSemantic proximity Read ↗

Role of miRNAs in Normal and Myasthenia Gravis ThymusSemantic proximity Read ↗

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read ↗

MicroRNAs in systemic rheumatic diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.